BLCM Market Cap History
Below is a table of the BLCM market cap history going back to 12/18/2014:

Date BLCM Market Cap
12/18/2014591.80M
3/15/2015602.22M
4/30/2015632.56M
7/31/2015539.14M
10/30/2015331.53M
2/29/2016243.31M
4/29/2016273.63M
7/29/2016429.53M
10/28/2016446.43M
2/28/2017334.85M
4/28/2017442.59M
7/28/2017366.82M
11/3/2017336.54M
2/28/2018233.32M
4/30/2018286.82M
7/31/2018275.70M
10/31/2018176.48M
3/1/2019145.37M
4/30/2019140.33M
7/31/201966.61M
10/31/201940.73M
2/6/202051.01M
2/28/202045.43M
5/1/202023.03M
7/31/202033.95M
10/30/202018.77M
3/22/202136.93M
5/10/202126.12M
8/4/202124.69M
10/27/202116.96M

Also see: BLCM Shares Outstanding History
and BLCM YTD Return
BLCM Historical Market Cap:
-40.42% CAGR
BLCM Historical Market Cap: +-40.42% CAGR

Mouse over chart for data details
12/18/2014 ...10/27/2021
Bellicum Pharmaceuticals is a clinical stage biopharmaceutical company focused on discovering and developing controllable cellular immunotherapies for various forms of cancer, including both hematological cancers and solid tumors. Co.'s programs include: BPX-601, which is designed to treat solid tumors expressing prostate stem cell antigen; BPX-603, which is designed to target solid tumors that express the human epidermal growth factor receptor 2 antigen; and Rivo-cel, which is intended to improve outcomes when administered after hematopoietic stem cell transplantation in the treatment of hematologic malignancies and inherited blood disorders. We show 30 historical shares outstanding datapoints in our BLCM shares outstanding history coverage, used to compute BLCM market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing BLCM market cap history over the course of time is important for investors interested in comparing BLCM's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of BLCM versus a peer is one thing; comparing BLCM market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like BLCM can fluctuate over the course of history. With this page we aim to empower investors researching BLCM by allowing them to research the BLCM market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree BLCM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Bellicum Pharmaceuticals (BLCM) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

BLFS Market Cap History
BLI Market Cap History
BLPH Market Cap History
BLRX Market Cap History
BLUE Market Cap History
BMEA Market Cap History
BMRA Market Cap History
BMRN Market Cap History
BMY Market Cap History
BNGO Market Cap History
More Healthcare companies »

 

BLCM Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.